Komen awards $5.4 million for cancer screening effort
July 2012

ST. LOUIS—Washington University in St. Louis and the Institute of Cancer Research in London recently received a $5.4 million grant from the Susan G. Komen for the Cure foundation, the bulk of which—$4 million—will go toward efforts to better identify which women with estrogen receptor-positive breast cancer, the most common form, face the greatest risk of recurrence, and to identify better treatments for them.
"There are so many new drugs out there for breast cancer patients that we need a way to establish which ones are most likely to be the home run," Matthew Ellis, professor of medicine and chief of the breast oncology section at Washington University School of Medicine, said in a statement. "Our goal is to screen drugs to find the one that will produce the best outcome for the patient with the least toxicity."

1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.